J-STAR Research and Porton Pharma Solutions Ltd. are excited to be exhibiting at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting at the Boston Convention Center on October 16th – 19th! Stay tuned for more information regarding our …
The year 2022 is an important milestone for Porton. Despite of the uncertainties of the external environment, we always keep in mind Porton’s mission of “Enabling public’s early access to good medicines” to overcome those challenges and ensure delivery through …
PORTON PHARMA SOLUTIONS LTD., a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API facility inside, Life Science Park Mengeš, Slovenia currently owned and operated by Lek Pharmaceuticals d.d., part of NOVARTIS
PORTON PHARMA SOLUTIONS LTD., a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API facility inside, Life Science Park Mengeš, Slovenia currently owned and operated by Lek Pharmaceuticals d.d., part of NOVARTIS …
Porton is excited to announce construction of a new, state-of-the-art Crystallization and Drug Product facility in Cranbury, NJ. The new building is projected to open in Q4 of 2022. This facility will be cGMP capable for Drug Product supplies, and …
We are very excited to announce the technical program of Pharma Crystallization Summit 2022. This year’s Summit is in-person only and the seats are limited. We cordially invite CMC leaders/managers of drug development programs, API crystallization experts or solution …
J-STAR Research is a proud sponsor of this year’s Empowering Women in Organic Chemistry Conference (EWOC). The EWOC has a mission of empowerment along with promoting networking, community, and amazing science! The EWOC is dedicated to equity, justice, diversity, …
J-STAR Research is a proud sponsor of this year’s Empowering Women in Organic Chemistry Conference (EWOC). The EWOC has a mission of empowerment along with promoting networking, community, and amazing science! The EWOC is dedicated to equity, justice, diversity, …
BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) — MetasTx LLC is driven to create novel therapeutics to treat and prevent metastasis of cancers. Harvey Homan, CEO and Co-Founder has successfully presented at Keiretsu Forum Mid-Atlantic and South East, the …
J-STAR Research is pleased to announce our collaboration in the 3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series, featuring an impressive line-up of speakers and topics.
This is a 4-week webinar series with a webinar every Wednesday from …
Expand small and medium-scale CDMO production capacity
March 10th, 2022, Shanghai · China – Porton Pharma Solutions Ltd. announced that it is to acquire 100% equity of China Gateway Pharmaceutical Development Co., Ltd. (referred to as “Gateway Pharmaceutical”), a CDMO …
March 1st, 2022, Chongqing · China – Porton Pharma Solutions Ltd. announced an investment of 420 million to expand CDMO Production Capacity of Small Molecule API in Porton Pharma (Jiangxi) Co., Ltd. which is mainly engaged in customized production of …
